SF3B1 and cancer: In UVM, SF3B1 mutation drives aberrant RNA splicing of BRD9, a key component essential for the noncanonical BRG1/BRM-associated factor chromatin-remodeling complex, which is required to maintain SF3B1-mutant cancers (12).